Embryo-restricted responses to maternal IL-17A promote neurodevelopmental disorders in mouse offspring

David Andruszewski,David C. Uhlfelder,Genni Desiato,Tommy Regen,Carsten Schelmbauer,Michaela Blanfeld,Lena Scherer,Konstantin Radyushkin,Davide Pozzi,Ari Waisman,Ilgiz A. Mufazalov
DOI: https://doi.org/10.1038/s41380-024-02772-6
IF: 11
2024-10-10
Molecular Psychiatry
Abstract:Prenatal imprinting to interleukin 17A (IL-17A) triggers behavioral disorders in offspring. However, reported models of maternal immune activation utilizing immunostimulants, lack specificity to elucidate the anatomical compartments of IL-17A's action and the distinct behavioral disturbances it causes. By combining transgenic IL-17A overexpression with maternal deficiency in its receptor, we established a novel model of prenatal imprinting to maternal IL-17A (acronym: PRIMA-17 model). This model allowed us to study prenatal imprinting established exclusively through embryo-restricted IL-17A responses. We demonstrated a transfer of transgenic IL-17A across the placental barrier, which triggered the development of selected behavioral deficits in mouse offspring. More specifically, embryonic responses to IL-17A resulted in communicative impairment in early-life measured by reduced numbers of nest retrieval calls. In adulthood, IL-17A-imprinted offspring displayed an increase in anxiety-like behavior. We advocate our PRIMA-17 model as a useful tool to study neurological deficits in mice.
biochemistry & molecular biology,neurosciences,psychiatry
What problem does this paper attempt to address?